The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo continues to escalate, reaching 11,376 confirmed cases and 5,568 deaths, with a concerning 72% case fatality rate among children under five. In Nigeria, a widespread diphtheria outbreak has surpassed 28,000 confirmed cases and 1,126 deaths amid significant vaccination gaps. Meanwhile, Russia faces a generalized HIV epidemic in 27 regions, with prevalence exceeding 1% among pregnant women. In the Americas, northern Mexico reports surging tick-borne rickettsiosis, with high case fatality rates in Coahuila, Sonora, and Chihuahua, while the United States has lost its measles elimination status following 5,182 cases. Finally, Qatar confirmed two MERS cases linked to camel exposure, its first since 2022, and Switzerland reported its first four locally acquired chikungunya cases.
Ebola virus disease, Democratic Republic of the Congo
The Bundibugyo Ebola outbreak continues to expand in the Democratic Republic of the Congo (DRC), with 11,376 confirmed cases and 5,568 deaths (CFR 48.9%) reported as of 14 November 2026. Transmission has affected 68 health zones across eight provinces, with Ituri remaining the epicentre (7,858 cases). Particularly concerning is the impact on children: 2,959 paediatric cases and 1,737 deaths were reported as of 4 November, with a case fatality rate of 72% among children under five years. In Kenya, nine cases and two deaths have been reported, with all patients discharged and contacts completing follow-up; the single imported case reported in Nigeria has also recovered.
MERS, Qatar
Qatar reported two confirmed MERS cases in August 2026, the first since 2022. Both cases occurred in men over 50 with chronic conditions and occupational exposure to dromedary camels at geographically separate farms. One case developed severe pneumonia requiring ventilatory support, but both patients recovered and were discharged. Contact tracing of 99 individuals, including healthcare workers, identified no secondary cases.
Diphtheria, Nigeria
Nigeria's ongoing outbreak, which began in 2022, has reached 37,529 suspected cases (28,151 confirmed) and 1,126 deaths as of 7 November 2026. Recent state-level activity includes Plateau State reporting 469 suspected cases in September and school closures, while Niger State reported 124 cases and 17 deaths in August. The outbreak is occurring amid vaccination gaps, with only 62% of children receiving all three recommended DTP doses.
HIV/AIDS, Russia
HIV transmission in Russia has reached a generalized epidemic stage in 27 regions, with HIV prevalence exceeding 1% among pregnant women, indicating transmission beyond traditionally recognised high-risk populations. More than 1.23 million people (0.8% of the population) are living with diagnosed HIV, with prevalence exceeding 3% among men aged 40–49 years. Approximately 30,000–34,000 HIV-related deaths occur annually, while only around half of people with diagnosed HIV have achieved viral suppression. Additionally, eight healthcare-associated outbreaks involving HIV and viral hepatitis affected 104 patients in 2025, highlighting persistent gaps in infection prevention and control.
Spotted fever group rickettsiosis, Mexico
Northern Mexico continues to report increasing cases and deaths from tick-borne rickettsiosis, predominantly Rocky Mountain spotted fever, with 75 cases and 51 deaths in Coahuila (CFR 68%), 150 cases and 62 deaths in Sonora (CFR 41%), and 152 cases and 73 deaths in Chihuahua (CFR 48%) reported between late October and early November 2026. Compared with the same period in 2025, cases increased by 150% in Coahuila, 49% in Sonora and 48% in Chihuahua. In Ciudad Juárez (Chihuahua), nearly half of confirmed cases (41/83) occurred among individuals under 20 years of age. The exceptionally high case fatality rates highlight the importance of early recognition and prompt doxycycline treatment, alongside tick-control measures targeting domestic dogs and peridomestic environments.
11,197 confirmed cases and 5,471 deaths reported, alongside imported cases in Nigeria and Kenya.
Two confirmed cases linked to occupational camel exposure; both recovered and no secondary transmission.
213 locally acquired cases in France, one in Italy, and four first-ever cases in Switzerland.
5,342 diagnosed cases reported since mid-May, the highest figure since the 2015–2016 epidemic.
37,529 suspected cases, including 28,151 confirmed, and 1,126 deaths reported as of November 2026.
5,182 cases and multiple deaths reported, resulting in the loss of elimination status.
Third VDPV1 case reported in Deir ez-Zor linked to two previously confirmed paralytic cases.
Generalized epidemic extends beyond high-risk groups across 27 regions; healthcare-associated transmission reported.
219 clade I cases reported in October 2026 across 15 countries, predominantly affecting MSM.
1,389 confirmed cases since 2023, with Clade Ib surpassing Clade IIb since July 2026.
1,883 locally acquired human cases and 148 deaths reported across 15 EU/EEA countries
28 confirmed cases and 5 hospitalisations across 13 states linked to raw oysters.
Multistate increase in cases and deaths in northern states, with national CFR exceeding 44%.
98,096 cases and 73 deaths reported in 2026, with outbreak status in 23 departments.
6,594 cases reported in 2026, a 57% increase, alongside 1,049 concurrent chikungunya cases.
Nearly 7,000 cases reported this year, prompting public health warnings amid expected rainy weather.
413 probable cases reported in weeks 40-44, predominantly affecting infants under one year.
Third confirmed case of 2026 reported, involving a fatal infection in Assaba region.
768 cases and 17 deaths reported in Gauteng between January and September 2026.
The ESCMID-AUMC Epi Alert, a strategic collaboration between the ESCMID Emerging Infections Subcommittee and the Center of Tropical Medicine and Travel Medicine of Amsterdam University Medical Center (AUMC) that integrates expertise and resources to advance emerging infectious diseases surveillance and intelligence sharing. This collaboration integrates ESCMID's extensive international network and emerging infections expertise with AUMC's proven surveillance capabilities, led by Dr. Abraham Goorhuis and the AUMC team and other collaborators form European Institutions.
The Epi Alert aims to be a weekly publication. The briefings are curated by infectious disease specialists prioritising data from trusted sources (such as Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC) based on potential impact, geographic region and urgency/relevancy to clinical practice. It aims to provide concise summaries for busy healthcare professionals with direct links for further investigation and transparency.
This integrated collaboration represents a significant milestone in ESCMID's commitment to emerging infections preparedness, strengthening our collective capacity to detect, analyse, and respond to infectious disease threats through international cooperation.
Disclaimer: The information in this epi-alert is a weekly summary of the information that is available on the internet, mainly the websites of Beacon, H-Radar, Outbreaknews, WHO, ECDC, CDC, and others. For this summary, we consider issues that are most relevant to the ESCMID members involved in clinical patient care. Therefore, this report is not comprehensive, but we strive to include all major global issues in this report on a weekly basis.